slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 89,551-89,580
Pages 3,225
Rows per page 30
Component
89,551-89,580 of 96,741
33
Includes a Kaplan-Meier survival curve as evidence for the clinical relevance of TLS.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
04
The slide highlights the pharmacodynamic (PD) effect of background corticosteroids in the placebo group, which was unexpected.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · InterestLoop · Aha Moment1 hit
08
The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solves.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide emphasizes the clinical value of rapid turnaround time in critical care settings.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a bottom-up market sizing approach based on patient volumes and testing frequency.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
04
Uses a visual metaphor of fluid dynamics (beakers and spheres) to explain viscosity reduction.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Includes a callout highlighting J&J's Darzalex Faspro achieving 85% conversion in under 2 years.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
11
Includes three distinct data panels: bar chart for viscosity, line charts for stability (SEC and IEX), and a dose-response curve for potency.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
15
Includes a screenshot of a press release and a callout box with key takeaways.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
05
The chart uses a stacked area visualization to show cumulative growth across different industry verticals.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
09
The slide uses a mix of bulleted statistics and circular callouts for key metrics.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
19
The slide uses a growth curve visualization to link product releases to market expansion.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
04
The slide lists 8 executives with their roles, tenure at Eos, and total years of experience, alongside a grid of logos representing their past/partner organizations.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Setup1 hit
11
The slide uses a numbered diagram to map components to the table.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
20
The chart uses a waterfall structure to show how specific initiatives (R&D, Engineering, Supply Chain, Operations) reduce the cost components (Materials, Labor, Overhead) over time.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
06
The slide details a specific corporate partnership agreement.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses a visual comparison to frame the problem of current therapeutic limitations.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The slide highlights the structural commonality of the γC receptor across multiple cytokines, positioning it as a therapeutic target.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
The slide uses a four-column structure to explain the target, molecular nature, preclinical results, and clinical status.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The slide uses a column-based layout to compare four distinct medical conditions, each with specific patient counts and development milestones.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
The slide uses Western blot data to visually demonstrate the efficacy of EQ101 compared to a standard JAK inhibitor.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Includes before/after patient photos and comparative data against Mogamulizumab.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
Includes visual longitudinal data (photos) and quantitative bar chart data.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
26
Includes a timeline diagram for the study phases and a target product profile comparison.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
30
Includes a disclaimer regarding the source of financial data (Form 10-Q).Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
31
The slide uses a simple list-based timeline format.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
09
The slide uses a 'Good, Better, Best' framework to organize the company's product portfolio.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Product1 hit
15
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit